
Celltrion Healthcare Launches Avastin Biosimilar 'Vegzelma' in Japan
- The world's second-largest bevacizumab market is expected to settle in Japan. - Expected sales synergy with ‘Herzuma’, the No. 1 prescription for trastuzumab in Japan, by strengthening the anticancer drug portfolio. Celltrion Healthcare strengthened …